Pernix Therapeutics Holdings is primarily focused on the development and commercialization of branded, generic and OTC pharmaceutical products. The company’s portfolio of branded products includes the Hawthorn Pharmaceuticals’ product line. In the pediatrics market, products include: CEDAX®, an antibiotic for middle ear infections; NATROBA™, a topical treatment for head lice; and a family of treatments for cough and cold. PTX’s branded products for gastroenterology include OMECLAMOX-PAK® and REZYST™. For more information, visit the company’s Web site: http://www.pernixtx.com

Let us hear your thoughts below: